FITX. .0605 pps CEN Biotech Inc. (FITX) Notifie
Post# of 97997
CEN Biotech Inc. (FITX) Notifies Health Canada that it’s facility is Ready for the Pre-License Inspection
MADISON HEIGHTS, MI / ACCESSWIRE / April 30, 14, 2014 / Creative Edge Nutrition, Inc. (PINKSHEETS: FITX), is proud to announce that it has notified Health Canada that its facility is ready for the Pre-License inspection. The company accelerated its construction and build-out plans for what will become the world’s largest and most advanced legal cannabis production facility.
Bill Chaaban stated “it is important for our company to receive its license from Health Canada as soon as possible. To fulfill this goal, we have redesigned the layout of our standing 27,000 square foot building to become a self-sustained complete operational production facility. It will have all of the state of the art technologies implemented into the design of our larger facility. This building will be completely compliant with our obligations as promised to Health Canada. We are proud to advise that on April 22, 2014 we notified Health Canada that our facility would be ready for the Pre-License Inspection. On April 29, 2014, we notified Health Canada that stage one of the facility was completed and is now ready for the pre-license inspection. As the company waits for the pre-license inspection, it will continue the build-out of the 53,000 square foot facility. We have implemented cGMP and USP 797 design and work flow models into the design and build-out of our buildings.”
About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR) CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.